COLLINGWOOD HEALTH GROUP
HAWKEYS LANE, NORTH SHIELDS
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 33 | 40 | 82.5% | |
| HF 4 | 2011 | 29 | 37 | 78.4% | |
| HF 4 | 2012 | 29 | 36 | 80.6% | |
| HF 4 | 2013 | 26 | 30 | 86.7% | |
| HF004 | 2014 | 8 | 8 | 100.0% | |
| HF004 | 2015 | 48 | 51 | 94.1% | |
| HF004 | 2016 | 85 | 90 | 94.4% | |
| HF004 | 2017 | 108 | 115 | 93.9% | |
| HF004 | 2018 | 131 | 136 | 96.3% | |
| HF004 | 2019 | 150 | 158 | 94.9% | |
| HF004 | 2020 | 144 | 162 | 88.9% | |
| HF006 | 2021 | 211 | 235 | 89.8% | |
| HF006 | 2022 | 206 | 230 | 89.6% | |
| HF006 | 2023 | 218 | 226 | 96.5% |
